70 related articles for article (PubMed ID: 18473514)
1. Probiotic bacteria for prophylaxis and therapy of candidiasis.
Balish E; Wagner RD
Rev Iberoam Micol; 1998 Dec; 15(4):261-4. PubMed ID: 18473514
[TBL] [Abstract][Full Text] [Related]
2. Biotherapeutic effects of Bifidobacterium spp. on orogastric and systemic candidiasis in immunodeficient mice.
Wagner RD; Warner T; Pierson C; Roberts L; Farmer J; Dohnalek M; Hilty M; Balish E
Rev Iberoam Micol; 1998 Dec; 15(4):265-70. PubMed ID: 18473515
[TBL] [Abstract][Full Text] [Related]
3. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice.
Wagner RD; Pierson C; Warner T; Dohnalek M; Farmer J; Roberts L; Hilty M; Balish E
Infect Immun; 1997 Oct; 65(10):4165-72. PubMed ID: 9317023
[TBL] [Abstract][Full Text] [Related]
4. Potential role of probiotic bacteria in the treatment and prevention of localised candidosis.
Mailänder-Sánchez D; Wagener J; Schaller M
Mycoses; 2012 Jan; 55(1):17-26. PubMed ID: 21672043
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
6. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
7. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
[TBL] [Abstract][Full Text] [Related]
8. Effects of probiotic bacteria on humoral immunity to Candida albicans in immunodeficient bg/bg-nu/nu and bg/bg-nu/+ mice.
Wagner RD; Dohnalek M; Hilty M; Vazquez-Torres A; Balish E
Rev Iberoam Micol; 2000 Jun; 17(2):55-9. PubMed ID: 15813696
[TBL] [Abstract][Full Text] [Related]
9. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
10. Postoperative fungal infections.
Eggimann P; Pittet D
Surg Infect (Larchmt); 2006; 7 Suppl 2():S53-6. PubMed ID: 16895507
[TBL] [Abstract][Full Text] [Related]
11. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
[TBL] [Abstract][Full Text] [Related]
12. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
13. Candida prophylaxis and therapy in the ICU.
Echeverria PM; Kett DH; Azoulay E
Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections.
Del Rosso JQ; Zellis S; Gupta AK
J Am Osteopath Assoc; 1998 Sep; 98(9):497-502. PubMed ID: 9785744
[TBL] [Abstract][Full Text] [Related]
15. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
16. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
17. Optimizing therapy for Candida infections.
Playford EG; Sorrell TC
Semin Respir Crit Care Med; 2007 Dec; 28(6):678-88. PubMed ID: 18095232
[TBL] [Abstract][Full Text] [Related]
18. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
[TBL] [Abstract][Full Text] [Related]
19. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.
Bassetti M; Righi E; Tumbarello M; Di Biagio A; Rosso R; Viscoli C
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):875-85. PubMed ID: 17140362
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
Healy CM; Campbell JR; Zaccaria E; Baker CJ
Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
